These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6420915)

  • 1. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
    Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
    Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
    [No Abstract]   [Full Text] [Related]  

  • 2. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
    Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN
    Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acquired immunodeficiency in a patient with hemophilia].
    Alkan M; Kuperman O; Goldstein G; Berginer V
    Harefuah; 1986 Aug; 111(3-4):74-6. PubMed ID: 3098652
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemophilia and acquired immune deficiency syndrome.
    Levine PH; Brettler DB; Sullivan JL
    Prog Clin Biol Res; 1985; 182():287-96. PubMed ID: 2994104
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acquired cellular immunodeficiency syndrome: 3 observations in hemophiliacs].
    Miranda ML; Leal M; Lissen E; Jiménez JM; Vinuesa M; Wichman I; García M; Digón J; Ollero M; Alonso JF
    Med Clin (Barc); 1983 Jun; 81(1):24-6. PubMed ID: 6412006
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired immunodeficiency syndrome (AIDS) in hemophilia.
    Evatt BL; Chorba TL
    Clin Lab Med; 1984 Jun; 4(2):333-44. PubMed ID: 6437735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
    Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
    Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
    Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P
    Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status and trends in the treatment of hemophilic patients with inhibitors.
    Bloom AL
    Prog Clin Biol Res; 1981; 72():123-38. PubMed ID: 6801682
    [No Abstract]   [Full Text] [Related]  

  • 10. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 11. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K; Schwarz P; Kunschak M
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract]   [Full Text] [Related]  

  • 12. AIDS and haemophilia.
    Bloom AL
    Biomed Pharmacother; 1985; 39(7):355-65. PubMed ID: 3938297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.
    Peerlinck K; Arnout J; Gilles JG; Saint-Remy JM; Vermylen J
    Thromb Haemost; 1993 Feb; 69(2):115-8. PubMed ID: 8456422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors.
    Bell BA
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):105-6. PubMed ID: 8447549
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons.
    Mokhbat JE; Naman RE; Rahme FS; Farah AE; Zahar KL; Maalouf A
    J Med Liban; 1989; 38(1):9-14. PubMed ID: 2519339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A].
    Kunst VA; Nováková IR; Haanen C
    Ned Tijdschr Geneeskd; 1989 Jun; 133(23):1163-6. PubMed ID: 2501689
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS and preventive treatment in hemophilia.
    Desforges JF
    N Engl J Med; 1983 Jan; 308(2):94-5. PubMed ID: 6216409
    [No Abstract]   [Full Text] [Related]  

  • 19. Burkitt-like lymphoma in a hemophilic boy with impaired cellular immunity.
    Aronis S; Tzortzatou F; Karaboulas K; Tsiftis G; Madalenakis K; Karpathios T
    Pediatrics; 1985 Aug; 76(2):289-91. PubMed ID: 3927255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors.
    Ceuppens JL; Vermylen J; Colaert J; Desmyter J; Gautama K; Stevens E; The AL; Vanham G; Vermylen C; Verstraete M
    Thromb Haemost; 1984 Apr; 51(2):207-11. PubMed ID: 6429883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.